FGF23 at the crossroads of phosphate, iron economy and erythropoiesis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FGF23 at the crossroads of phosphate, iron economy and erythropoiesis
Authors
Keywords
-
Journal
Nature Reviews Nephrology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-13
DOI
10.1038/s41581-019-0189-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia
- (2018) Rafiou Agoro et al. FASEB JOURNAL
- Oral Versus Intravenous Iron Supplementation for the Treatment of Iron Deficiency Anemia in Patients on Maintenance Hemodialysis—Effect on Fibroblast Growth Factor-23 Metabolism
- (2018) Wataru Fukao et al. JOURNAL OF RENAL NUTRITION
- Erythropoietin induces bone marrow and plasma fibroblast growth factor 23 during acute kidney injury
- (2018) Luis Toro et al. KIDNEY INTERNATIONAL
- Effects of erythropoietin on fibroblast growth factor 23 in mice and humans
- (2018) Mark R Hanudel et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Burosumab Therapy in Children with X-Linked Hypophosphatemia
- (2018) Thomas O. Carpenter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Erythropoietin stimulates fibroblast growth factor 23 (FGF23) in mice and men
- (2018) Arezoo Daryadel et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model
- (2018) Hidekazu Sugiura et al. PLoS One
- Targeting Fibroblast Growth Factor 23 Signaling with Antibodies and Inhibitors, Is There a Rationale?
- (2018) Seiji Fukumoto Frontiers in Endocrinology
- α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling
- (2018) Gaozhi Chen et al. NATURE
- Anemia of inflammation
- (2018) Guenter Weiss et al. BLOOD
- Intact FGF23 and α-klotho during acute inflammation/sepsis in CKD patients
- (2017) Evangelia Dounousi et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Erythropoietin stimulates murine and human fibroblast growth factor-23, revealing novel roles for bone and bone marrow
- (2017) Erica L. Clinkenbeard et al. HAEMATOLOGICA
- C-Terminal Fibroblast Growth Factor 23, Iron Deficiency, and Mortality in Renal Transplant Recipients
- (2017) Michele F. Eisenga et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- FGF23 is synthesised locally by renal tubules and activates injury-primed fibroblasts
- (2017) Edward R. Smith et al. Scientific Reports
- Erythropoietin stimulates murine and human fibroblast growth factor-23, revealing novel roles for bone and bone marrow
- (2017) Erica L. Clinkenbeard et al. HAEMATOLOGICA
- High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients
- (2017) Hirokazu Honda et al. PLoS One
- FGF23 expression in rodents is directly induced via erythropoietin after inhibition of hypoxia inducible factor proline hydroxylase
- (2017) Ingo Flamme et al. PLoS One
- Hepcidin in the diagnosis of iron disorders
- (2016) D. Girelli et al. BLOOD
- Serum fibroblast growth factor 23, serum iron and bone mineral density in premenopausal women
- (2016) Erik A. Imel et al. BONE
- Fibroblast growth factor 23 in acute burn patients: Novel insights from an intact-form assay
- (2016) Anne-Françoise Rousseau et al. BURNS
- Serum Fibroblast Growth Factor 23 (FGF23) in Patients with Rheumatoid Arthritis
- (2016) Hiroe Sato et al. INTERNAL MEDICINE
- Cord Blood Ferritin and Fibroblast Growth Factor-23 Levels in Neonates
- (2016) Farah N. Ali et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- CYP24 inhibition as a therapeutic target in FGF23-mediated renal phosphate wasting disorders
- (2016) Xiuying Bai et al. JOURNAL OF CLINICAL INVESTIGATION
- Fibroblast Growth Factor 23 and the Risk of Infection-Related Hospitalization in Older Adults
- (2016) Kristen L. Nowak et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- C-Terminal to Intact Fibroblast Growth Factor 23 Ratio in Relation to Estimated Glomerular Filtration Rate in Elderly Population
- (2016) Maria Bożentowicz-Wikarek et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production
- (2016) Valentin David et al. KIDNEY INTERNATIONAL
- Iron deficiency anaemia
- (2016) Anthony Lopez et al. LANCET
- Update on FGF23 and Klotho signaling
- (2016) Reinhold G. Erben MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Spleen contributes significantly to increased circulating levels of fibroblast growth factor23 in response to lipopolysaccharide-induced inflammation
- (2016) Shweta Bansal et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Klotho modulates FGF23-mediated NO synthesis and oxidative stress in human coronary artery endothelial cells
- (2016) Beatrice Richter et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Effects of intravenous iron on fibroblast growth factor 23 (FGF23) in haemodialysis patients: a randomized controlled trial
- (2016) Matthew A. Roberts et al. BMC Nephrology
- Excessive Osteocytic Fgf23 Secretion Contributes to Pyrophosphate Accumulation and Mineralization Defect in Hyp Mice
- (2016) Sathish K. Murali et al. PLOS BIOLOGY
- Long-term iron polymaltose infusions associated with hypophosphataemic osteomalacia: a report of two cases and review of the literature
- (2016) Ramy H. Bishay et al. Therapeutic Advances in Endocrinology and Metabolism
- Inflammation but not obesity or insulin resistance is associated with increased plasma fibroblast growth factor 23 concentration in the elderly
- (2015) Michał Holecki et al. CLINICAL ENDOCRINOLOGY
- Membrane and Integrative Nuclear Fibroblastic Growth Factor Receptor (FGFR) Regulation of FGF-23
- (2015) Xiaobin Han et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Iron Supplementation Associated With Loss of Phenotype in Autosomal Dominant Hypophosphatemic Rickets
- (2015) Klaus Kapelari et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- FGF23 gene regulation by 1,25-dihydroxyvitamin D: opposing effects in adipocytes and osteocytes
- (2015) Ichiro Kaneko et al. JOURNAL OF ENDOCRINOLOGY
- Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli
- (2015) Nobuaki Ito et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Fibroblast growth factor is associated to left ventricular mass index, anemia and low values of transferrin saturation
- (2015) Baris Eser et al. NEFROLOGIA
- Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease
- (2015) Maren Leifheit-Nestler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Potential Predictors of Plasma Fibroblast Growth Factor 23 Concentrations: Cross-Sectional Analysis in the EPIC-Germany Study
- (2015) Romina di Giuseppe et al. PLoS One
- Associations of Fibroblast Growth Factor-23 with Markers of Inflammation, Insulin Resistance and Obesity in Adults
- (2015) Lynae J. Hanks et al. PLoS One
- Coupling fibroblast growth factor 23 production and cleavage
- (2014) Myles Wolf et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Genetic Rescue of Glycosylation-deficient Fgf23 in theGalnt3Knockout Mouse
- (2014) Shoji Ichikawa et al. ENDOCRINOLOGY
- FGF-23 Is a Negative Regulator of Prenatal and Postnatal Erythropoiesis
- (2014) Lindsay M. Coe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Interleukin-1-induced acute bone resorption facilitates the secretion of fibroblast growth factor 23 into the circulation
- (2014) Miwa Yamazaki et al. JOURNAL OF BONE AND MINERAL METABOLISM
- The Kidney Is the Principal Organ Mediating Klotho Effects
- (2014) K. Lindberg et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Molecular interactions of FGF23 and PTH in phosphate regulation
- (2014) Beate Lanske et al. KIDNEY INTERNATIONAL
- Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription
- (2014) Tomer Meir et al. KIDNEY INTERNATIONAL
- FGF23 protein expression in coronary arteries is associated with impaired kidney function
- (2014) Natalie A. van Venrooij et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis
- (2014) V. S. Tagliabracci et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A systematic analysis of global anemia burden from 1990 to 2010
- (2013) N. J. Kassebaum et al. BLOOD
- Regulation of erythropoiesis by hypoxia-inducible factors
- (2013) Volker H. Haase BLOOD REVIEWS
- Disordered FGF23 and Mineral Metabolism in Children with CKD
- (2013) A. A. Portale et al. Clinical Journal of the American Society of Nephrology
- Effects of Dietary Phosphate Restriction and Phosphate Binders on FGF23 Levels in CKD
- (2013) T. Isakova et al. Clinical Journal of the American Society of Nephrology
- Calcium Regulates FGF-23 Expression in Bone
- (2013) Valentin David et al. ENDOCRINOLOGY
- Exome sequencing reveals FAM20c mutations associated with fibroblast growth factor 23-related hypophosphatemia, dental anomalies, and ectopic calcification
- (2013) Silje Hjorth Rafaelsen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women
- (2013) Myles Wolf et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Neonatal Iron Deficiency Causes Abnormal Phosphate Metabolism by Elevating FGF23 in Normal and ADHR Mice
- (2013) Erica L Clinkenbeard et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Insulin resistance is associated with Fibroblast Growth Factor-23 in stage 3–5 chronic kidney disease patients
- (2013) Jocelyn S. Garland et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Fibroblast Growth Factor-23 and Cardiovascular Events in CKD
- (2013) J. J. Scialla et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Plasma FGF23 levels increase rapidly after acute kidney injury
- (2013) Marta Christov et al. KIDNEY INTERNATIONAL
- FGF-23 and secondary hyperparathyroidism in chronic kidney disease
- (2013) Justin Silver et al. Nature Reviews Nephrology
- Effect of ferric carboxymaltose on serum phosphate and C-terminal FGF23 levels in non-dialysis chronic kidney disease patients: post-hoc analysis of a prospective study
- (2013) Merche Prats et al. BMC Nephrology
- High dose intravenous iron, mineral homeostasis and intact FGF23 in normal and uremic rats
- (2013) Eva Gravesen et al. BMC Nephrology
- Predictors of intact and C-terminal fibroblast growth factor 23 in Gambian children
- (2013) Vickie Braithwaite et al. Endocrine Connections
- Fibroblast growth factor 23 contributes to diminished bone mineral density in childhood inflammatory bowel disease
- (2012) Mostafa Abdel-Aziz El-Hodhod et al. BMC GASTROENTEROLOGY
- Molecular Mechanisms of Vitamin D Action
- (2012) Mark R. Haussler et al. CALCIFIED TISSUE INTERNATIONAL
- The effects of iron on FGF23-mediated Ca–P metabolism in CKD patients
- (2012) Serpil Muge Deger et al. Clinical and Experimental Nephrology
- Fibroblast Growth Factor 23 and Inflammation in CKD
- (2012) J. Munoz Mendoza et al. Clinical Journal of the American Society of Nephrology
- Fibroblast Growth Factor 23-Related Osteomalacia Caused by the Prolonged Administration of Saccharated Ferric Oxide
- (2012) Sunao Yamamoto et al. INTERNAL MEDICINE
- Nuclear fibroblast growth factor 2 (FGF2) isoforms inhibit bone marrow stromal cell mineralization through FGF23/FGFR/MAPK in vitro
- (2012) Liping Xiao et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Biological Variability of Plasma Intact and C-Terminal FGF23 Measurements
- (2012) Edward R. Smith et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Circulating αKlotho influences phosphate handling by controlling FGF23 production
- (2012) Rosamund C. Smith et al. JOURNAL OF CLINICAL INVESTIGATION
- Calcium Deficiency Reduces Circulating Levels of FGF23
- (2012) M. E. Rodriguez-Ortiz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Update on fibroblast growth factor 23 in chronic kidney disease
- (2012) Myles Wolf KIDNEY INTERNATIONAL
- Oral calcium carbonate affects calcium but not phosphorus balance in stage 3–4 chronic kidney disease
- (2012) Kathleen M. Hill et al. KIDNEY INTERNATIONAL
- Inactivation of a Novel FGF23 Regulator, FAM20C, Leads to Hypophosphatemic Rickets in Mice
- (2012) Xiaofang Wang et al. PLoS Genetics
- Effect of Intravenous Saccharated Ferric Oxide on Serum FGF23 and Mineral Metabolism in Hemodialysis Patients
- (2011) Yoko Takeda et al. AMERICAN JOURNAL OF NEPHROLOGY
- PTH Ablation Ameliorates the Anomalies ofFgf23-Deficient Mice by Suppressing the Elevated Vitamin D and Calcium Levels
- (2011) Quan Yuan et al. ENDOCRINOLOGY
- Novel mutations in GALNT3 causing hyperphosphatemic familial tumoral calcinosis
- (2011) Alan Yancovitch et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Iron Modifies Plasma FGF23 Differently in Autosomal Dominant Hypophosphatemic Rickets and Healthy Humans
- (2011) Erik A. Imel et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
- (2011) Tamara Isakova et al. KIDNEY INTERNATIONAL
- Residual renal function is an independent determinant of serum FGF-23 levels in dialysis patients
- (2011) L. Viaene et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice
- (2011) E. G. Farrow et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- FGF23 or PTH: which comes first in CKD ?
- (2010) Tamara Isakova et al. KIDNEY INTERNATIONAL
- Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease
- (2010) Hisashi Hasegawa et al. KIDNEY INTERNATIONAL
- Hypophosphatemia induced by intravenous administration of saccharated ferric oxide
- (2009) Yuichiro Shimizu et al. BONE
- Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model
- (2009) Teruyo Nakatani et al. FASEB JOURNAL
- Defective O-Glycosylation due to a Novel Homozygous S129P Mutation Is Associated with Lack of Fibroblast Growth Factor 23 Secretion and Tumoral Calcinosis
- (2009) Clemens Bergwitz et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- FGF23 Elevation and Hypophosphatemia after Intravenous Iron Polymaltose: A Prospective Study
- (2009) Belinda J. Schouten et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Circulating Fibroblast Growth Factor 23 in Patients with End-Stage Renal Disease Treated by Peritoneal Dialysis Is Intact and Biologically Active
- (2009) Takashi Shimada et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease
- (2009) P. Manghat et al. OSTEOPOROSIS INTERNATIONAL
- Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation
- (2009) R. Goetz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993–2005
- (2008) Erin McLean et al. PUBLIC HEALTH NUTRITION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now